Back to search
FDAFDA · Food and drugs·Recall number D-1542-2020

BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01

Published September 2, 2020 · Recall initiated: August 10, 2020

Summary

FDA records drug Class II recall D-1542-2020, published September 2, 2020 and initiated August 10, 2020. Recalling firm: Par Pharmaceutical Inc.; Status: Terminated; Reported quantity: 11,347 bottles; Lot: Lot # 32091002, exp. date May 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity /Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Par Pharmaceutical Inc.
Distributor
Product was distributed to 9 major distributors throughout the United States.
Lot
Lot # 32091002, exp. date May 2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01 recalled?

Yes. FDA published recall D-1542-2020 on September 2, 2020. Reported hazard: Failed Impurity /Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter